Gabon vs Guinea-Bissau: Population requiring preventive chemotherapy for schistosomiasis
Gabon
204,568
in 2024
Guinea-Bissau
399,321
in 2024
Gabon rank
42nd
Guinea-Bissau rank
41st
Population requiring preventive chemotherapy for schistosomiasis over time
- Gabon
- Guinea-Bissau
How they compare
Guinea-Bissau currently reports 399,321 against 204,568 in Gabon, a difference of 194,753.
That makes Guinea-Bissau's figure about 2.0 times Gabon's.
The two have swapped places 3 times across 15 shared years of data; in 2010 it was Gabon ahead.
Gabon ranks 42nd and Guinea-Bissau ranks 41st of 52 countries.
Across the 2 decades both report, Gabon averaged higher in 1 and Guinea-Bissau in 1.
Head to head by decade
| Decade | Gabon | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 274,188 | 219,316 | 54,871 | Gabon |
| 2020s | 192,392 | 221,684 | 29,292 | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Gabon or Guinea-Bissau?
- Guinea-Bissau, at 399,321 against 204,568 in Gabon as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Gabon and Guinea-Bissau?
- 194,753, with Guinea-Bissau ahead.
- How many years of comparable data are there for Gabon and Guinea-Bissau?
- 15 years are reported by both, from 2010 to 2024.
- How do Gabon and Guinea-Bissau rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Gabon ranks 42nd and Guinea-Bissau ranks 41st of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.